0001415889-24-012552.txt : 20240507
0001415889-24-012552.hdr.sgml : 20240507
20240507200558
ACCESSION NUMBER: 0001415889-24-012552
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240507
FILED AS OF DATE: 20240507
DATE AS OF CHANGE: 20240507
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Washington Julie
CENTRAL INDEX KEY: 0001544191
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34885
FILM NUMBER: 24923870
MAIL ADDRESS:
STREET 1: C/O JAMBA, INC.
STREET 2: 6475 CHRISTIE AVENUE, NO. 150
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMYRIS, INC.
CENTRAL INDEX KEY: 0001365916
STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 550856151
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5885 HOLLIS STREET, SUITE 100
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 510-450-0761
MAIL ADDRESS:
STREET 1: 5885 HOLLIS STREET, SUITE 100
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: AMYRIS BIOTECHNOLOGIES INC
DATE OF NAME CHANGE: 20060613
4
1
form4-05082024_120551.xml
X0508
4
2024-05-07
1
0001365916
AMYRIS, INC.
AMRS
0001544191
Washington Julie
C/O AMYRIS, INC.
5885 HOLLIS STREET, SUITE 100
EMERYVILLE
CA
94608
true
false
false
false
0
Common Stock
2024-05-07
4
J
0
19166
0
D
0
D
Pursuant to the Issuer's Third Amended Joint Plan of Reorganization Pursuant to Chapter 11 of the Bankruptcy Code, which was confirmed by the United States Bankruptcy Court for the District of Delaware on February 7, 2024 and became effective on May 7, 2024, each share of the Issuer's common stock and options to purchase the Issuer's common stock outstanding prior to the Issuer's emergence from bankruptcy were cancelled for no value.
In August 2023, pursuant to an agreement between the Reporting Person and the Issuer, the Reporting Person forfeited all unvested restricted stock unit awards and stock option awards granted pursuant to the Issuer's Non-Employee Director Compensation Program.
/s/ Julie Washington
2024-05-07